{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:14:19Z","timestamp":1753892059391,"version":"3.41.2"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>In China, 80% of Hepatocellular Carcinoma (HCC) is associated with cirrhosis. Portal hypertension, the most common outcome of cirrhosis progression, has a high incidence. Platelet count\/spleen diameter ratio (PSL) with a cut-off value of 909 can predict the presence of esophagogastric varices and thus portal hypertension, which is also an independent risk factor for early recurrence and late recurrence of hepatocellular carcinoma after resection. Therefore, the effect of PSL on the overall survival (OS) of patients with HCC is necessary. The aim of this study was to apply a new method to establish and validate a model for predicting the prognosis of patients based on PSL with HCC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A total of 1,104 patients with clinical diagnosed with HCC following non-surgical therapy randomly divided the patients into a primary cohort and a validation cohort in a ratio of 7:3, in which 772 HCC patients were in the primary cohort and a total of 332 HCC patients were in the validation cohort. Through Lasso-Cox analysis, the independent predictors of OS of training cohort were included in nomogram1, and the independent predictors of Cox regression analysis were included in nomogram2. Nomogram1 and nomogram2 used consistency index (C-index), AUC and time-dependent ROC curves in the training cohort, respectively, and the calibration curves were plotted. All suggest that nomogram1 is better than nomogram2. We get similar results in the validation cohort.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The C-index of nomogram1was 0.792 (95%CI: 0.772\u20130.812), which was superior to nomogram2 (0.788) and traditional modes (0.631\u20130.712). The AUC of nomogram1 was 0.866 (95%CI: 0.840\u20130.889). In the validation cohort, the nomogram1 still gave good discrimination (C-index: 0.769, 95%CI: 0.740\u20130.798; AUC: 0.867, 95%CI: 0.826\u20130.902). Calibration plots for 3-year OS probabilities showed the good agreement between nomogram1 predictions and actual observations. In addition, we found that the decision curve analysis of nomogram1 and nomogram2 was also meaningful.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Novel nomogram containing PSL, based on LASSO Cox regression, had higher predictive efficacy for 3-year overall survival in patients with HCC.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2024.1449603","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T07:05:09Z","timestamp":1736147109000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Survival analysis of patients with hepatocellular carcinoma based on the ratio of platelet count to spleen diameter"],"prefix":"10.3389","volume":"15","author":[{"given":"Huiwen","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongdong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1002\/hep.25949","article-title":"Complicated relationships of amino acid substitution in hepatitis C virus core region and IL28B genotype influencing hepatocarcinogenesis","volume":"56","author":"Akuta","year":"2012","journal-title":"Hepatology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1007\/s11605-011-1538-2","article-title":"Significance of platelet count in the outcomes of hepatectomized patients with hepatocellular carcinoma exceeding the Milan criteria","volume":"15","author":"Amano","year":"2011","journal-title":"J. Gastrointest. Surg."},{"key":"B4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2407-14-43","article-title":"Platelet extracts induce growth, migration and invasion in human hepatocellular carcinoma in vitro","volume":"14","author":"Carr","year":"2014","journal-title":"BMC Cancer"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1111\/jgh.14537","article-title":"Thrombocytopenia: a prognostic factor for hepatocellular carcinoma patients with portal vein tumor thrombus after hepatectomy","volume":"34","author":"Cheng","year":"2019","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"CD008759","DOI":"10.1002\/14651858.CD008759.pub2","article-title":"Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis","volume":"4","author":"Colli","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.3969\/j.issn.1000-8179.2020.24.149","article-title":"Analysis and comparison of common prognostic prediction models for liver cancer","volume":"47","author":"Dongdong","year":"2020","journal-title":"Chin. J. Clin. Oncol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1182\/blood-2014-08-531582","article-title":"Platelets at the interface of thrombosis, inflammation, and cancer","volume":"126","author":"Franco","year":"2015","journal-title":"Blood"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.3748\/wjg.v20.i10.2595","article-title":"Management of thrombocytopenia due to liver cirrhosis: a review","volume":"20","author":"Hayashi","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.3390\/cancers12113215","article-title":"Antiplatelet therapy improves the prognosis of patients with hepatocellular carcinoma","volume":"12","author":"Hayashi","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1200\/JCO.2007.12.9791","article-title":"How to build and interpret a nomogram for cancer prognosis","volume":"26","author":"Iasonos","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1007\/s00268-013-1902-3","article-title":"Clinicopathological features of recurrence in patients after 10-year disease-free survival following curative hepatic resection of hepatocellular carcinoma","volume":"37","author":"Kaibori","year":"2013","journal-title":"World J. Surg."},{"key":"B13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ajg.2012.06.004","article-title":"Clinical significance of elevated alpha-foetoprotein (AFP) in patients with chronic hepatitis C without hepatocellular carcinoma in upper Egypt","volume":"13","author":"Kobeisy","year":"2012","journal-title":"Arab. J. Gastroenterol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.5754\/hge10649","article-title":"Characteristics and surgical outcome of HCC patients with low platelet count","volume":"59","author":"Kondo","year":"2012","journal-title":"Hepatogastroenterology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1007\/s00535-012-0656-2","article-title":"Accumulation of platelets in the liver may be an important contributory factor to thrombocytopenia and liver fibrosis in chronic hepatitis C","volume":"48","author":"Kondo","year":"2013","journal-title":"J. Gastroenterol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.hepres.2004.10.005","article-title":"Correlation between low platelet count and multicentricity of hepatocellular carcinoma in patients with chronic hepatitis C","volume":"30","author":"Kubo","year":"2004","journal-title":"Hepatol. Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1111\/liv.12817","article-title":"Pretreatment platelet count early predicts extrahepatic metastasis of human hepatoma","volume":"35","author":"Lee","year":"2015","journal-title":"Liver Int."},{"key":"B19","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1634\/theoncologist.2018-0305","article-title":"Tumor size affects efficacy of adjuvant transarterial chemoembolization in patients with hepatocellular carcinoma and microvascular invasion","volume":"24","author":"Liu","year":"","journal-title":"Oncologist"},{"key":"B20","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s12072-020-10046-w","article-title":"Machine learning-based development and validation of a scoring system for progression-free survival in liver cancer","volume":"14","author":"Liu","year":"2020","journal-title":"Hepatol. Int."},{"key":"B21","doi-asserted-by":"publisher","first-page":"152930","DOI":"10.1016\/j.phymed.2019.152930","article-title":"Effects of adjuvant traditional Chinese medicine therapy on long-term survival in patients with hepatocellular carcinoma","volume":"62","author":"Liu","year":"","journal-title":"Phytomedicine"},{"key":"B22","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.jamcollsurg.2011.01.004","article-title":"Importance of low preoperative platelet count in selecting patients for resection of hepatocellular carcinoma: a multi-institutional analysis","volume":"212","author":"Maithel","year":"2011","journal-title":"J. Am. Coll. Surg."},{"key":"B23","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.dld.2011.12.016","article-title":"Platelet count\/spleen diameter ratio for non-invasive diagnosis of oesophageal varices: is it useful in compensated cirrhosis?","volume":"44","author":"Mangone","year":"2012","journal-title":"Dig. Liver Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.jhep.2018.10.022","article-title":"Role of liver and spleen stiffness in predicting the recurrence of hepatocellular carcinoma after resection","volume":"70","author":"Marasco","year":"2019","journal-title":"J. Hepatol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10555-014-9498-0","article-title":"Platelets and cancer: a casual or causal relationship: revisited","volume":"33","author":"Menter","year":"2014","journal-title":"Cancer Metastasis Rev."},{"key":"B26","doi-asserted-by":"publisher","first-page":"E353","DOI":"10.1111\/hepr.12315","article-title":"Involvement of platelets in extrahepatic metastasis of hepatocellular carcinoma","volume":"44","author":"Morimoto","year":"2014","journal-title":"Hepatol. Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"7895","DOI":"10.3748\/wjg.v21.i25.7895","article-title":"Thrombocytopenia for prediction of hepatocellular carcinoma recurrence: systematic review and meta-analysis","volume":"21","author":"Pang","year":"","journal-title":"World J. Gastroenterol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e1431","DOI":"10.1097\/MD.0000000000001431","article-title":"The prognostic value of platelet count in patients with hepatocellular carcinoma: a systematic review and meta-analysis","volume":"94","author":"Pang","year":"","journal-title":"Med. Baltim."},{"key":"B29","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1111\/liv.12878","article-title":"Addition of tumor multiplicity improves the prognostic performance of the hepatoma arterial-embolization prognostic score","volume":"36","author":"Park","year":"2016","journal-title":"Liver Int."},{"key":"B30","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1111\/liv.13317","article-title":"Thrombocytopenia in chronic liver disease","volume":"37","author":"Peck-Radosavljevic","year":"2017","journal-title":"Liver Int."},{"key":"B31","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.coph.2007.04.004","article-title":"Gamma-glutamyltransferase, redox regulation and cancer drug resistance","volume":"7","author":"Pompella","year":"2007","journal-title":"Curr. Opin. Pharmacol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1002\/hep.25832","article-title":"Resection of hepatocellular cancer \u22642cm: results from two Western centers","volume":"57","author":"Roayaie","year":"2013","journal-title":"Hepatology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.radonc.2019.05.006","article-title":"Postoperative adjuvant IMRT for patients with HCC and portal vein tumor thrombus: an open-label randomized controlled trial","volume":"140","author":"Sun","year":"2019","journal-title":"Radiother. Oncol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"B35","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/(sici)1097-0258(19970228)16:4<385::aid-sim380>3.0.co;2-3","article-title":"The Lasso method for variable selection in the Cox model","volume":"16","author":"Tibshirani","year":"1997","journal-title":"Stat. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"B37","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/ajg.2012.445","article-title":"Hepatocellular carcinoma surveillance at 4- vs. 12-month intervals for patients with chronic viral hepatitis: a randomized study in community","volume":"108","author":"Wang","year":"2013","journal-title":"Am. J. Gastroenterol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1097\/MCG.0b013e31825ceeb5","article-title":"Prognostic significance of computed tomography scan-derived splenic volume in hepatocellular carcinoma treated with radiofrequency ablation","volume":"46","author":"Wu","year":"2012","journal-title":"J. Clin. Gastroenterol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"10944","DOI":"10.3748\/wjg.v20.i31.10944","article-title":"Model based on \u03b3-glutamyltransferase and alkaline phosphatase for hepatocellular carcinoma prognosis","volume":"20","author":"Xu","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s007950300006","article-title":"Nuclear localization of alkaline phosphatase in cultured human cancer cells","volume":"36","author":"Yamamoto","year":"2003","journal-title":"Med. Electron Microsc."},{"key":"B41","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13244-024-01609-8","article-title":"Prediction of late recurrence after curative-intent resection using MRI-measured spleen volume in patients with hepatocellular carcinoma and cirrhosis","volume":"15","author":"Yang","year":"2024","journal-title":"Insights Imaging"},{"key":"B42","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.cgh.2010.08.019","article-title":"Cirrhosis is present in most patients with hepatitis B and hepatocellular carcinoma","volume":"9","author":"Yang","year":"2011","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"4237","DOI":"10.7150\/jca.33430","article-title":"Impact of gender as a prognostic factor in HBV-related Hepatocellular Carcinoma: the survival strength of female patients in BCLC stage 0-B","volume":"10","author":"Yu","year":"2019","journal-title":"J. Cancer"},{"key":"B44","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1186\/s12935-021-02214-1","article-title":"Serum GGT\/ALT ratio predicts vascular invasion in HBV-related HCC","volume":"21","author":"Zhao","year":"2021","journal-title":"Cancer Cell Int."},{"key":"B45","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s12885-021-07916-3","article-title":"A prognostic nomogram based on LASSO Cox regression in patients with alpha-fetoprotein-negative hepatocellular carcinoma following non-surgical therapy","volume":"21","author":"Zhou","year":"2021","journal-title":"BMC Cancer"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1449603\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T07:05:13Z","timestamp":1736147113000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1449603\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,6]]},"references-count":43,"alternative-id":["10.3389\/fphar.2024.1449603"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1449603","relation":{},"ISSN":["1663-9812"],"issn-type":[{"type":"electronic","value":"1663-9812"}],"subject":[],"published":{"date-parts":[[2025,1,6]]},"article-number":"1449603"}}